Resonex RX4000 Magnetic Resonance Imaging System
PMA P860062
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA PMAAPPR | NumberP860062 | Date25 May 1988 | StatusActive |
Recalls
No FDA recalls found in the data synced 6 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA PMA Active
Specification
- Full name
- Resonex RX4000{TM} Magnetic Resonance Imaging Syst
- Generic Name
- System, nuclear magnetic resonance imaging
- PMA Number
- FDA Product Code
- LNH
- Device Class
- Class II
- Regulation
- 21 CFR Part 892.1000
- Advisory Committee
- Radiology
- FDA Decision
- APPR Approved
- PMA Supplement
- S001 (THIRTY DAY TRACK)
Overview
AI-generated summary, 18 Sep 2026
The Resonex RX4000 Magnetic Resonance Imaging System is a nuclear magnetic resonance imaging system designed for diagnostic radiology. It generates detailed images of the internal structures of the body using magnetic fields and radio waves, enabling clinicians to evaluate anatomical and pathological conditions.
This system is intended for use in radiology departments and clinical settings where MRI capabilities are required. It is classified as a Class II device under FDA regulations and has received FDA Premarket Approval (PMA). The device is not specified as single-use or reusable, nor are MRI safety classifications or sterility details provided in the data. Multiple registration numbers and product codes (e.g., LNH) are associated with its regulatory filings.
Other devices from Resonex, Inc.
Questions
AI-generated answers, 18 Sep 2026
What is the primary use case for the Resonex RX4000 Magnetic Resonance Imaging System in a clinical setting?
The Resonex RX4000 Magnetic Resonance Imaging System is designed for diagnostic radiology, enabling detailed imaging of internal body structures using magnetic fields and radio waves. Clinicians use it to evaluate anatomical and pathological conditions, making it ideal for radiology departments where MRI capabilities are essential.
How was the regulatory approval process for this MRI system structured, and what does that tell me about its compliance?
The Resonex RX4000 received FDA Premarket Approval (PMA) under PMA number P860062, which is the highest level of approval for medical devices in the U.S. This indicates that the device underwent rigorous review by the FDA to ensure its safety, effectiveness, and compliance with regulatory standards before being authorized for market distribution.
Is the Resonex RX4000 Magnetic Resonance Imaging System intended for single-use or repeated use in clinical environments?
The provided data does not specify whether the Resonex RX4000 MRI system is designed for single-use or repeated use. MRI systems are generally not classified as single-use devices, as they are intended for long-term, repeated use in clinical settings. For precise usage guidelines, consult the manufacturer’s instructions or maintenance documentation.
What type of facility or department would typically house this MRI system, and why?
This MRI system is intended for use in radiology departments or clinical settings where advanced imaging is required. Its design and regulatory classification (Class II) align with the needs of specialized diagnostic environments, such as hospitals or dedicated imaging centers, where detailed anatomical evaluations are performed.